- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Tata Capital Healthcare Fund II infuses USD 10 million in Apex Kidney Care
Overview
Tata Capital, a prominent private equity (PE) firm, has announced a substantial investment of USD 10 million in Mumbai-based dialysis chain Apex Kidney Care (AKC), securing an undisclosed equity stake in the process.
This funding has been channeled through Tata Capital Healthcare Fund II (TCHF II), a private equity fund with a specific focus on the healthcare sector.
As per various media reports, out of the USD 10 million investment, approximately 90% will be allocated for fueling the growth of Apex Kidney Care, while the remaining 10% will provide an exit opportunity for specific angel investors. Founded by nephrologists Jatin Kothari and Viswanath Billa, AKC has garnered financial support from both its founders and angel investors.
For more details, check out the link given below:
Tata Capital Health Division Pours USD 10 Million Investment Into Apex Kidney Care